Back to Journals » Vascular Health and Risk Management » Volume 8

ESR rate can be a marker for coronary artery disease

Authors Eghbal Eftekhaari T

Received 10 October 2012

Accepted for publication 10 October 2012

Published 18 December 2012 Volume 2012:8 Pages 669—670


Checked for plagiarism Yes

Tasnim Eghbal Eftekhaari

Clinical Research Development Center of Shahid Mohammadi Hospital, Research Center for Cardiovascular Diseases, Department of Research and Technology, Hormozgan University of Medical Sciences, Bandar-e-Abbas, Iran

The aim of Yayan’s1 study was to utilize the erythrocyte sedimentation rate (ESR) as a rapid guide to identify patients with acute coronary syndrome (ACS) or myocardial infarction. ESR is arguably a nonspecific biomarker which is elevated in almost every condition. Prakash et al2 have pointed to conflicting reports in the literature documenting the tendency of patients with periodontitis to develop anemia. Hence, this study was undertaken to assess whether periodontitis can cause an anemic state by evaluating and comparing the red blood cell count and levels of hemoglobin, hematocrit, ESR, serum iron, and serum ferritin between subjects with and without periodontitis, anemia, rheumatoid arthritis, and other hematologic conditions.1 However, this study shows that there is no statistically significant difference between rates of ESR in men and women. The purpose of referring to this reference is that most elderly people suffer from periodontitis and this condition is not negligible given that many older people also suffer for concomitant ischemic heart disease. Inflammation arising within the gastrointestinal tract may be of great importance in the pathogenesis of irritable bowel syndrome,2 regarding this fact that ESR is commonly used to assess the acute phase response,3 this acute phase response may be nonspecific. Elevated ESR is seen more often in elderly patients than in their younger counterparts3 (imagine an elderly patient with elevated ESR and consider whether ESR would be used as the sole basis for diagnosis of heart pain? Of course not!). ESR elevated concomitantly with C-reactive protein is used to confirm adult-onset Still’s disease.4 In an adult who is a heavy smoker with dyslipidemia, a personal history of Still’s disease, and a family history of ischemic heart disease, would you consider Still’s disease or ACS first?

View original paper by Yayan.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other article by this author:

Efficacy of musculoskeletal injections given by primary care providers in the office

Eghbal Eftekhaari T, Nazarnejhad M, Ghasemzadeh I

International Journal of General Medicine 2013, 6:773-775

Published Date: 16 September 2013

Readers of this article also read:

Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries

Cimino E, Linari S, Malerba M, Halimeh S, Biondo F, Westfeld M

Patient Preference and Adherence 2014, 8:1713-1720

Published Date: 12 December 2014

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K

Neuropsychiatric Disease and Treatment 2014, 10:1793-1798

Published Date: 18 September 2014

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al

International Journal of Nanomedicine 2010, 5:581-591

Published Date: 6 August 2010

Does plasmin have anticoagulant activity?

Jane Hoover-Plow

Vascular Health and Risk Management 2010, 6:199-205

Published Date: 26 March 2010